The ACCE Student Scholarship is now the Mario Castañeda Scholarship. A tribute to ACCE past president Mario Castañeda, the scholarship furthers his legacy to promote the profession and encourage eligible students to pursue a health technology/clinical engineering/biomedical engineering career path.
The American College of Clinical Engineering will award one $1,500 scholarship to a student studying to become a clinical engineer. An additional travel stipend of up to $1,000 will be provided for the student's travel expenses to attend the annual conference and the ACCE awards reception. The scholarship will be awarded at the annual members meeting in June.
Requirements and Criteria:
- ACCE membership is NOT required
- Applicants must be a current (beginning in the fall of 2024), full-time, third-year or above undergraduate or recent graduates accepted into a related graduate program, seeking a career in clinical engineering/biomedical engineering/health systems engineering profession at an accredited college or university
The 2024 Mario Castañeda Scholarship will be awarded on June 15, 2024 at the ACCE awards reception in Phoenix,AZ.
2024 Mario Castañeda Scholarship application.
Click here.
2024 Mario Castañeda Scholarship application is now closed.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Please support the Mario Castañeda Scholarship program - with a contribution of any amount.
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
We appreciate and are grateful to those who have already contributed to the 2024 Mario Castaneda Scholarship Fund:
- Ray Zambuto
- Hank Stankiewicz
- Suly Chi
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------